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MICAbstract In an attempt to ﬁnd a new class of antimicrobial agents, a series of novel N0-(5 or 7
substituted-2-oxoindolin-3-ylidene)benzofuran-2-carbohydrazides 3(a–p) were synthesized by react-
ing benzofuran-2-carbohydrazide 1 with 5 and 7 substituted-isatins 2(a–p). The synthesized com-
pounds were conﬁrmed by melting point, IR, 1H NMR, 13C NMR and mass spectroscopy. All
the synthesized compounds were screened for antimicrobial activity among the tested series, 3o
exhibited excellent antibacterial activity against Escherichia coli and Pseudomonas vulgaris while
3p against Bacillus subtilis, E. coli and P. vulgaris (31.25 lg/mL) when compared with standards.
Similarly 3o and 3p showed signiﬁcant antifungal activity (31.25 lg/mL) when compared to ﬂuco-
nazole against Aspergillus niger.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Human struggle against the afﬂiction of disease, decay and
death is eternal. The deterioration of human population due
to an enhanced prevalence of infectious diseases is becoming
a global problem. The contemporary treatment of infectious
diseases involves administration of a multidrug regimen over
a long period of time, which has led to the rapid emergence
of multidrug-resistant strains plus a high level of patient non-
compliance (Chambhare et al., 2003). The rising prevalence of
multidrug resistant superbugs like methicillin-resistant Staphy-
lococcus aureus (MRSA) and vancomycin-resistant Enterococ-cus faecium (VREF) continues to provide impetus for the
search and discovery of novel antimicrobial agents. A potential
approach to overcome this resistance problem is to design new
and innovative agents with a completely different mode of ac-
tion so that no cross-resistance with the present therapeutics
can occur (Khan et al., 2005).
Among an extensive diversity of heterocycles that have
been explored for developing pharmaceutically important mol-
ecules, benzofuran derivatives have played an important role
in medicinal chemistry. Benzofuran derivatives have drawn
considerable attention due to their profound physiological
and chemotherapeutic properties. Benzofuran has a variety
of activities like antimicrobial (Khan et al., 2005; Alper-Hayta
et al., 2008), anti-inﬂammatory (Jadhav et al., 2008), antican-
cer (Mahboobi et al., 2007; Asoh et al., 2009), antihistaminer-
gic (Gfesser et al., 2005; Peschke et al., 2006; Cowart et al.,
2005) and anticholinesterase (Luo et al., 2005; Belluti et al.,
2005). Several attempts were made to study the effects of dif-
ferent functional groups on the homocycle and/or the hetero-
cycle for bioactivity. On the other hand isatin, an indole
S390 V. Ugale et al.derivative possesses good antimicrobial activity (Pandeya
et al., 1999; Pandeya and Sriram, 1998; Mirjana et al., 2006).
In the view of biological importance of these two moieties,
the present work was undertaken to synthesize a new series
of benzofurano-substituted isatins and to evaluate their possi-
ble anti-microbial activity.
2. Rationale and hypothesis
The chemistry of benzofurans available in a large number of
natural products has attracted widespread interest due to their
biological activities and their potential applications as pharma-
cological agents. Several benzofuran ring systems bearing var-
ious substituents at the C-2 position are widely distributed in
nature. There are well known natural products having related
benzofuran ring structures, the most recognized benzofurans
are ailanthoidol, amiodarone and bufuralol compounds. Ailan-
thoidol, a neolignan with a 2-arylbenzofuran skeleton, was iso-
lated from the Chinese herbal medicine Zanthoxylum
ailanthoides (Fuganti and Serra, 1998). It has been reported
that neolignans and lignans possess a variety of biological
activities such as anticancer, antiviral, immunosuppressive,
antioxidant, antifungal and antifeedant activities (Kao and
Chern, 2001). Cicerfuran, another antifungal benzofuran deriv-
ative, was ﬁrst obtained from the roots of wild species of chick-
pea, Cicer bijugum, reported to be a major factor in the defence
system against Fusarium wilt (Aslam et al., 2009) (Fig. 1).
Benzofuran derivatives are of special interest to natural
product researchers for their biological activities and potentialFigure 1 Reported and prapplications as pharmacological agents, e.g. corsifuran C
(Xiao et al., 2008; Toshio et al., 2004; Kuete et al., 2009). Spe-
ciﬁcally, several benzofuran ring systems bearing various sub-
stituents at C-2 and C-3 positions are widely distributed in
nature, the stilbenoids structural compounds, e.g. an oligostil-
bene derivative viniferin, are known to possess antimicrobial,
antiviral, antioxidant, antifungal, and antitumor activities
(Lin and Yao, 2006; Kim et al., 2008).
Isatin an endogenous compound identiﬁed in many organ-
isms shows a wide range of biological activities (Pandeya
et al., 2005). The isatin ring is a prominent structural moiety
found in several pharmaceutically active compounds. This is
mainly due to the easy synthesis and the importance of phar-
macological activity. Therefore, the synthesis and selective
functionalization of isatins have been the focus of active
research area over the years (Lian-Shun et al., 2011). Isatin
derivatives are reported to show antibacterial (Praveen
et al., 2011) and antifungal (Amalraj et al., 2003) activities.
Methisazone, for example plays an important role as
prophylactic agent against several viral diseases (Foye and
Sethi, 2002).
Prompted by the above-mentioned results, it was planned
to combine two biologically active pharmacophore benzofuran
and substituted isatins for the construction of some benzofu-
ran–isatins. These combinations were suggested in an attempt
to investigate the possible synergistic inﬂuence of such struc-
ture hybridizations on the anticipated activity, hoping to dis-
cover a new lead structure that would have a signiﬁcant
antimicrobial activity at very small concentration.oposed structure 3(a–p).
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In the present work, 16 novel derivatives of benzofurano-
substituted isatins were synthesized 3(a–p). The synthetic strat-
egies adopted to obtain the target compounds are depicted in
Scheme 1. The 5 and 7 substituted-isatins 2(a–p) and benzofu-
ran-2-carbohydrazide 1 were prepared as per the reported
methods given by Henry and Blatt (1964) andMarvel and Heirs
(1941), respectively. Finally 5 and 7 substituted-isatins 2(a–p)
and benzofuran-2-carbohydrazide 1 were reﬂuxed in absolute
ethanol with 2–3 drops of glacial acetic acid as a catalyst to
afford corresponding N0-(5 and 7 substituted-2-oxoindolin-3-
ylidene)benzofuran-2-carbohydrazide 3(a–p). All the synthe-Schemesized compounds were characterized by their physical (Table 1),
analytical, and spectral data.
The mechanism of the reaction involves in the synthesis of
N0-(5 and 7 substituted-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazides 3(a–p) is nucleophilic addition of benzofu-
ran-2-carbohydrazide to 5 and 7 substituted-isatins to give
N0-(5 and 7 substituted-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazides as shown in Scheme 2.
4. Result and discussion
All the synthesized compounds were characterized by their
physical and spectral data. The IR spectra of all the1
Table 1 Physical data of benzofurano-isatins 3(a–p).
Compounds Molecular
formula
Molecular
weight
Yield (%) Melting
point (C)
3a C17H11N3O3 305.29 76.64 320–322
3b C17H10BrN3O3 384.18 73.12 312–314
3c C17H10ClN3O3 339.73 75.47 318–320
3d C17H10FN3O3 323.28 64.45 339–341
3e C18H13N3O3 319.31 74.16 315–317
3f C18H13N3O4 335.31 70.15 320–322
3g C17H10N4O5 350.29 72.60 306–308
3h C17H11N3O4 321.29 71.14 311–314
3i C17H10BrN3O3 384.18 71.40 316–318
3j C17H10ClN3O3 339.73 75.58 321–323
3k C17H11N3O4 321.29 70.57 315–317
3l C18H13N3O3 319.31 71.23 313–315
3m C18H13N3O4 335.31 69.76 319–321
3n C19H15N3O4 349.34 63.12 329–331
3o C17H10N4O5 350.29 71.34 309–311
3p C17H10FN3O3 323.28 69.15 335–337
aElemental analysis for C, H, N were within 0.4% of the theoretical
values.
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3180 cm1 due to amidal –NH– stretch. The title compounds
were also conﬁrmed by the appearance of bands at 1724–
1697 cm1 due to >C‚O stretch of isatins. The 1H NMR
(DMSO-d6) spectrum of compounds 3(a–p) exhibited proton
absorption singlet at 11.64–12.85 ppm and 10.97–10.01 ppm
due to CONH- and indole –NH–, respectively. All other aro-
matic protons were observed as multiplet in the range 8.21–
5.75 ppm. The 13C NMR and mass spectra of the compounds
3(a–p) were in agreement with the proposed structures.
In the present research we planned to combine two biolog-
ically active moieties such as benzofuran and isatin to observe
inﬂuence over the biological activity since several benzofuran
ring systems are known to possess signiﬁcant antimicrobial
activity as reported by Xiao et al. (2008), Toshio et al.
(2004) and Kuete et al. (2009). Similarly isatin moiety also pos-
sesses good antimicrobial activity as described by Pandeya
et al. (1999), Pandeya and Sriram (1998), Mirjana et al.
(2006). Newly prepared compounds 3(a–p) were screened for
their antibacterial and antifungal activity. MICs were recorded
as the minimum concentration of a compound that inhibits the
growth of tested microorganisms. The MIC values are gener-
ally within the range of 31.25–500 lg/mL against all evaluated
strains. The results of the in vitro antibacterial activity screen-
ing of the novel series of N0-(5-bromo-2-oxoindolin-3-yli-
dene)benzofuran-2-carbohydrazides 3(a–p) are summarized in
Table 2, against the Gram-positive bacteria S. aureus
(ATCC-25923) and Bacillus subtilis (ATCC 6633), the Gram-
negative bacteria Escherichia coli (ATCC-25922) and Pseudo-
monas vulgaris (ATCC-27853). Anti-microorganism tests with
16 compounds have established some interesting structure–
activity relationships. Compound 3o with a nitro group at C-7 of isatins, displayed excellent antibacterial activities against
E. coli and P. vulgaris with MIC values of 31.25 lg/mL as
compared to the positive control drugs. The presence of ﬂuoro
group at the C-7 position, compound 3p, also displayed good
activities against B. subtilis, E. coli and P. vulgaris with an
MIC value of 31.25 lg/mL as compared to standard drugs.
Surprisingly both 3o and 3p are less active against S. aureus.
Among the tested series 3c, 3d, 3i, 3j, 3k, 3m, 3n exhibited
moderate antibacterial activity against Gram positive bacteria
(S. aureus and B. subtilis) as well as Gram negative bacteria
(E. coli and P. vulgaris) with MIC values of 62.50–125 lg/
mL. However, rest of the compounds in the series were found
to have less or poor activity against tested micro-organisms as
compared to the standard drugs. It is interesting to note that
the introduction of an electron withdrawing substituent to
the aromatic ring at C5 and C7 positions resulted in com-
pounds with an excellent antibacterial activity as it is con-
ﬁrmed by 3o and 3p. However, an electron releasing
substituent gives compounds with poor activity, as it is ob-
served in compounds 3e and 3i.
All the synthesized N0-(5-bromo-2-oxoindolin-3-yli-
dene)benzofuran-2-carbohydrazides 3(a–p) were also screened
for antifungal activity against two fungal species Candida albi-
cans and Aspergillus niger. Compounds 3o and 3p displayed
good activity (31.25 lg/mL) against A. niger. The results
showed that compounds 3c, 3d, 3g, 3i, 3j, 3m, 3n showed mod-
erate activity (62.50–125 lg/mL) when compared to ﬂuconaz-
ole against A. niger. In case of C. albicans, except 3o and 3p,
all the tested compounds 3(a–p) displayed weak anti-fungal
activities as compared to standard (ﬂuconazole).
5. Conclusion
In the present research, we report the synthesis and in vitro
antimicrobial activity of a new series of novel benzofurano–
isatins 3(a–p). In general, the results of the in vitro antibacte-
rial activity are also encouraging, as out of 16 compounds
tested, compound 3o with a nitro group at C-7 of isatins exhib-
ited signiﬁcant antibacterial activity against E. coli and P. vul-
garis with MIC values of 31.25 lg/mL. Similarly the presence
of ﬂuoro group at the C-7 position, compound 3p, also dis-
played good activities against B. subtilis, E. coli and P. vulgaris
with an MIC value of 31.25 lg/mL as compared to standard
drugs. In case of antifungal activity compounds 3o and 3p dis-
played moderate activity (31.25 lg/mL) against A. niger when
compared to ﬂuconazole against A. niger. It is worth mention-
ing that the combination of two biologically active moieties
benzofurano and isatin profoundly inﬂuences the biological
activity. Possible improvements in the antimicrobial activity
can be further achieved by slight modiﬁcations in the substitu-
ents and/or additional structural activity investigations to have
good antifungal activity. Further developments on this subject
to understand their mechanistic interactions are currently in
progress.6. Experimental
All chemicals and solvents were supplied by Merck, S.D. Fine
Chemical Limited, Mumbai. All the solvents were distilled and
dried before use. The reactions were monitored with the help
of thin-layer chromatography using pre-coated aluminium
Scheme 2
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Melting points of the synthesized compounds were recorded
on the Veego (VMP-MP) melting point apparatus. IR spec-
trum was acquired on a Shimadzu Infra Red Spectrometer,
(model FTIR-8400S). Both 1H NMR (DMSO) and 13C
NMR (DMSO) spectra of the synthesized compounds were
performed with Bruker Avance-II 400 NMR Spectrometer
operating at 400 MHz in SAIF, Punjab University (Chandi-
garh). Chemical shifts were measured relative to internal stan-
dard TMS (d: 0). Chemical shifts are reported in d scale (ppm).
Mass (FAB) spectra of the synthesized compounds were re-
corded at MAT 120 in SAIF, Punjab University.
6.1. General procedure for the synthesis of N0-(5 or 7
substituted-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide 3(a–p)
A mixture of equimolar quantity of substituted indole-2,3-
dione 2(a–p) (1.47 g, 0.01 mol), benzofuran-2-carbohydrazide
(1.82 g, 0.01 mol) was taken in a 100 mL round bottom ﬂask
in absolute ethanol (20 mL) with 2–3 drops of glacial acetic
acid. The solution was reﬂuxed for three hours and allowed
to cool. The precipitated product was ﬁltered, dried and puri-
ﬁed by ﬂash chromatography using mobile phase ethyl ace-tate:chloroform (1:8). The solid product was crystallized by
using ethanol.
6.1.1. N0-(2-Oxoindolin-3-ylidene)benzofuran-2-carbohydrazide
(3a)
IR [KBr] vmax: 3225 (NH stretch), 3116 (CH stretch), 1698
(C‚O), 1670 (C‚N); 1H NMR (DMSO-d6) d: 12.85 (s, 1H,
CONH), 10.18 (s, 1H, indole NH), 6.67–5.75 (m, 9H, Ar–H);
13C NMR (DMSO-d6) d: 165.1, 158.5, 151.1, 127.4, 125.5,
124.5, 119.8, 110.9, 107.1 (benzofuran-2-carbohydrazide),
169.1, 140.5, 135.1, 130.0, 127.1, 122.1, 118.5, 116.1 (indo-
line-2,3-dione); HRMS (EI) m/z calcd for C17H11N3O3:
305.0800; found: 305.0805.
6.1.2. N0-(5-Bromo-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide (3b)
IR [KBr] vmax: 3200 (NH stretch), 3027 (CH stretch), 1708
(C‚O), 1668 (C‚N), 742 (C–Br stretch); 1H NMR
(DMSO-d6) d: 11.97 (s, 1H, CONH), 10.67 (s, 1H, indole
NH), 7.91–7.33 (m, 8H, Ar–H); 13C NMR (DMSO-d6) d:
164.1, 155.1, 148.2, 127.2, 125.1, 124.6, 120.1, 110.5, 108.2
(benzofuran-2-carbohydrazide), 168.9, 141.6, 137.1, 134.5,
130.1, 117.1, 116.4, 115.9 (5-bromoindoline-2,3-dione); HRMS
(EI) m/z calcd for C17H10BrN3O3: 382.9906; found: 382.9910.
Table 2 Minimum inhibitory concentration (MIC) of benzo-
furan–isatins 3(a–p).
CompoundsMIC corresponding eﬀects on micro-organism (lg/mL)
Antibacterial activity Antifungal
activity
Gram positive Gram negative
S.
aureus
B.
subtilis
E.
coli
P.
vulgaris
C.
albicans
A.
niger
3a 500 250 500 500 500 250
3b 250 250 250 250 250 250
3c 125 62.50 125 125 250 125
3d 125 62.50 62.50 62.50 250 62.50
3e 500 250 250 250 500 250
3f 250 250 250 500 500 250
3g 62.50 62.50 125 125 250 62.50
3h 125 62.50 125 125 250 125
3i 125 62.50 125 125 250 62.50
3j 62.50 125 62.50 125 250 62.50
3k 62.50 125 125 125 250 125
3l 500 250 250 250 500 250
3m 125 62.50 125 62.50 500 250
3n 125 62.50 125 62.50 500 250
3o 250 62.50 31.25 31.25 62.50 31.25
3p 250 31.25 31.25 31.25 62.50 31.25
Ampicillin 0.48 3.90 3.90 3.90 – –
Norﬂoxacin 0.48 3.90 0.12 62.50 – –
Fluconazole – – – – 0.98 1.95
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carbohydrazide (3c)
IR [KBr] vmax: 3197 (NH stretch), 3034 (CH strech), 1710
(C‚O), 1682 (C‚N stretch), 792 (C–Cl stretch); 1H NMR
(DMSO-d6) d: 11.76 (s, 1H, CONH), 10.49 (s, 1H, indole
NH), 7.91–6.97 (m, 8H, Ar–H); 13C NMR (DMSO-d6) d:
167.6, 156.1, 149.6, 125.5, 123.2, 122.1, 119.9, 111.1, 108.1
(benzofuran-2-carbohydrazide), 169.4, 138.9, 135.1, 133.1,
131.4, 128.5, 126.1, 119.6 (5-chloroindoline-2,3-dione); HRMS
(EI) m/z calcd for C17H10ClN3O3: 339.0411; found: 339.0416.
6.1.4. N0-(5-Fluoro-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide (3d)
IR [KBr] vmax: 3219 (NH stretch), 3110 (CH strech), 1697
(C‚O), 1667 (C‚N stretch), 1010 (C–F stretch); 1H NMR
(DMSO-d6) d: 11.56 (s, 1H, CONH), 10.53 (s, 1H, indole
NH), 7.94–7.12 (m, 8H, Ar–H); 13C NMR (DMSO-d6) d:
165.4, 156.8, 148.2, 125.8, 123.5, 122.1, 120.5, 111.7, 108.2
(benzofuran-2-carbohydrazide), 169.3, 159.0, 137.1, 133.9,
118.9, 116.6, 111.9, 109.2 (5-ﬂuroindoline-2,3-dione); HRMS
(EI) m/z calcd for C17H10FN3O3: 323.0706; found: 323.0701.
6.1.5. N0-(5-Methyl-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide (3e)
IR [KBr] vmax: 3227 (NH stretch), 3124 (CH stretch), 1700
(C‚O), 1675 (C‚N stretch); 1H NMR (DMSO-d6) d: 11.64(s, 1H, CONH), 10.28 (s, 1H, indole NH), 7.93–7.21 (m, 8H,
Ar–H), 2.25 (3H, s, CH3);
13C NMR (DMSO-d6) d: 168.5,
155.7, 149.6, 127.2, 125.1, 124.1, 120.1, 111.7, 108.5 (benzofu-
ran-2-carbohydrazide), 168.9, 138.5, 135.1, 133.4, 131.2, 127.1,
122.3, 115.9, 22.8 (5-methylindoline-2,3-dione); HRMS (EI) m/z
calcd for C18H13N3O3: 319.0957; found: 319.0963.
6.1.6. N0-(5-Methoxy-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide (3f)
IR [KBr] vmax: 3258 (NH stretch), 3068 (CH stretch), 1719
(C‚O), 1651 (C‚N stretch); 1H NMR (DMSO-d6) d: 11.79
(s, 1H, CONH), 10.97 (s, 1H, indole NH), 8.15–7.81 (m, 8H,
Ar–H), 3.79 (s, 3H, OCH3);
13C NMR (DMSO-d6) d: 167.2,
156.9, 148.7, 127.4, 125.9, 124.0, 120.6, 111.3, 108.7
(benzofuran-2-carbohydrazide), 168.7, 155.9, 134.1, 132.8,
123.2, 117.4, 115.3, 110.7, 57.1 (5-methoxyindoline-2,3-dione);
HRMS (EI) m/z calcd for C18H13N3O4: 335.0906; found:
335.0911.
6.1.7. N0-(5-Nitro-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide (3g)
IR [KBr] vmax: 3220 (NH stretch), 3056 (CH stretch) 1704
(C‚O), 1677 (C‚N stretch), 1520 (NO2 stretch);
1H NMR
(DMSO-d6) d: 11.75 (s, 1H, CONH), 10.18 (s, 1H, indole
NH), 7.91–7.02 (m, 8H, Ar–H); 13C NMR (DMSO-d6) d:
165.7, 155.8, 148.7, 127.4, 124.9, 123.8, 120.5, 111.7, 108.1 (ben-
zofuran-2-carbohydrazide), 169.7, 146.9, 142.3, 136.6, 124.9,
122.1, 120.0, 117.5 (5-nitroindoline-2,3-dione); HRMS (EI)
m/z calcd for C17H10N4O5: 350.0651; found: 350.0655.
6.1.8. N0-(5-Hydroxy-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide (3h)
IR [KBr] vmax: 3625 (OH stretch), 3194 (NH stretch), 3028
(CH stretch), 1710 (C‚O), 1640 (C‚N); 1H NMR (DMSO-
d6) d: 11.85 (s, 1H, CONH), 10.39 (s, 1H, indole NH), 7.91–
7.02 (8H, m, Ar–H); 13C NMR (DMSO-d6) d: 167.5, 158.1,
151.0, 125.8, 123.9, 123.0, 120.6, 110.9, 108.2 (benzofuran-2-
carbohydrazide), 169.7, 155.3, 135.9, 132.4, 121.9, 117.6,
116.9, 112.9 (5-hydroxyindoline-2,3-dione); HRMS (EI) m/z
calcd for C17H11N3O4: 321.0750; found: 321.0756.
6.1.9. N0-(7-Bromo-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide (3i)
IR [KBr] vmax: 3185 (NH stretch), 3078 (CH stretch), 1710
(C‚O), 1676 (C‚N), 726 (C–Br stretch); 1H NMR
(DMSO-d6) d: 11.72 (s, 1H, CONH), 10.51 (s, 1H, indole
NH), 7.72–7.35 (m, 8H, Ar–H); 13C NMR (DMSO-d6) d:
164.9, 156.6, 149.3, 127.7, 124.4, 122.9, 119.8, 111.2, 108.1
(benzofuran-2-carbohydrazide), 169.5, 141.7, 135.9, 135.2,
129.1, 126.1, 123.9, 118.1 (7-bromoindoline-2,3-dione); HRMS
(EI) m/z calcd for C17H10BrN3O3: 382.9906; found: 382.9911.
6.1.10. N0-(7-Chloro-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide (3j)
IR [KBr] vmax: 3184 (NH stretch), 3067 (CH stretch), 1706
(C‚O), 1683 (C‚N); 1H NMR (DMSO-d6) d: 11.95 (s, 1H,
CONH), 10.62 (s, 1H, indole NH), 7.91–7.17 (m, 8H, Ar–H);
13C NMR (DMSO-d6) d: 165.6, 156.3, 150.7, 127.7, 125.8,
123.9, 120.3, 110.7, 108.1 (benzofuran-2-carbohydrazide),
168.6, 138.7, 135.1, 133.9, 129.7, 126.1, 123.4, 118.0 (7-chloro-
indoline-2,3-dione); HRMS (EI) m/z calcd for C17H10ClN3O3:
339.0411; found: 339.0416.
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carbohydrazide (3k)
IR [KBr] vmax: 3249 (NH stretch), 3029 (CH stretch), 1713
(C‚O), 1639 (C‚N), 1H NMR (DMSO-d6) d: 11.72 (s, 1H,
CONH), 10.22 (s, 1H, indole NH), 7.84–7.11 (m, 8H, Ar–H);
13C NMR (DMSO-d6) d: 165.7, 156.5, 149.8, 127.3, 125.1,
122.9, 120.5, 111.0, 108.1 (benzofuran-2-carbohydrazide);
169.0, 147.1, 137.0, 127.6, 124.3, 121.3, 118.0, 116.9 (7-
hydroxyindoline-2,3-dione); HRMS (EI) m/z calcd for
C17H11N3O4, 321.0750; found: 321.0756.
6.1.12. N0-(7-Methyl-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide (3l)
IR [KBr] vmax: 3195 (NH stretch), 3045 (CH stretch), 1724
(C‚O), 1680 (C‚N); 1H NMR (DMSO-d6) d: 11.76 (s, 1H,
CONH), 10.01 (s, 1H, indole NH), 7.71–7.03 (m, 8H, Ar–H);
13C NMR (DMSO-d6) d: 167.8, 156.4, 149.4, 127.2, 124.1,
122.9, 119.7, 110.4, 107.8 (benzofuran-2-carbohydrazide),
169.4, 143.4, 134.1, 131.5, 128.1, 126.5, 124.1, 116.9, 19.4 (7-
methylindoline-2,3-dione); HRMS (EI) m/z calcd for
C18H13N3O3: 319.0957 found: 319.0961.
6.1.13. N0-(7-Methoxy-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide (3m)
IR [KBr] vmax: 3278 (NH stretch), 3101 (CH stretch), 1712
(C‚O), 1665 (C‚N), 1H NMR (DMSO-d6) d: 11.82 (s, 1H,
CONH), 10.34 (s, 1H, indole NH), 8.21–7.72 (m, 8H, Ar–H),
3.89 (s, 3H, OCH3);
13C NMR (DMSO-d6) d: 167.1, 155.8,
149.5, 127.5, 125.0, 123.7, 120.5, 111.1, 108.3 (benzofuran-2-
carbohydrazide), 169.6, 146.8, 134.9, 126.1, 125.2, 120.1,
117.9, 111.9, 56.7 (7-methoxyindoline-2,3-dione); HRMS (EI)
m/z calcd for C18H13N3O4: 335.0906; found: 335.0911.
6.1.14. N0-(7-Ethoxy-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide (3n)
IR [KBr] vmax: 3235 (NH stretch), 3081 (CH stretch), 1709
(C‚O), 1671 (C‚N), 1H NMR (DMSO-d6) d: 11.82 (s, 1H,
CONH), 10.34 (s, 1H, indole NH), 8.12–7.90 (m, 8H, Ar–H),
3.78 (q, 3H, OCH2), 2.41 (t, 2H, CH3);
13C NMR (DMSO-
d6) d: 167.7, 156.2, 149.4, 127.1, 125.5, 124.2, 120.3, 111.0,
108.2 (benzofuran-2-carbohydrazide), 168.4, 148.2, 133.2,
127.1, 125.5, 121.8, 119.1, 117.0, 62.9, 16.9 (7-ethooxyindo-
line-2,3-dione); HRMS (EI) m/z calcd for C19H15N3O4:
349.1063; found: 349.1069.
6.1.15. N0-(7-Nitro-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide (3o)
IR [KBr] vmax: 3290 (NH stretch), 3064 (CH stretch), 1716
(C‚O), 1658 (C‚N), 1H NMR (DMSO-d6) d: 11.65 (s, 1H,
CONH), 10.45 (s, 1H, indole NH), 8.05–7.65 (m, 8H, Ar–H);
13C NMR (DMSO-d6) d: 168.4, 158.1, 150.9, 127.1, 125.8,
124.1, 119.3, 110.5, 108.1 (benzofuran-2-carbohydrazide);
167.2, 143.3, 137.1, 133.9, 132.4, 126.9, 124.1, 117.1 (7-nitro-
indoline-2,3-dione); HRMS (EI) m/z calcd for C17H10N4O5:
350.0651; found: 350.0656.
6.1.16. N0-(7-Fluoro-2-oxoindolin-3-ylidene)benzofuran-2-
carbohydrazide (3p)
IR [KBr] vmax: 3257 (NH stretch), 3058 (CH stretch), 1718
(C‚O), 1666 (C‚N); 1H NMR (DMSO-d6) d: 11.98 (s, 1H,
CONH), 10.72 (s, 1H, indole NH), 7.91–7.17 (m, 8H, Ar–H);
13C NMR (DMSO-d6) d: 164.6, 154.2, 147.1, 126.8, 123.9,122.5, 120.3, 110.8, 109.3 (benzofuran-2-carbohydrazide),
168.4, 161.4, 135.9, 125.1, 123.9, 122.0, 117.9, 115.8 (7-ﬂuoro-
indoline-2,3-dione); HRMS (EI) m/z calcd for C17H10FN3O3:
323.0706 found: 323.0711.
7. Antimicrobial activity
All the test compounds were evaluated for the antibacterial
activity against (Koneman et al., 1997; NCCLS, 2002) the
Gram positive S. aureus (ATCC-25923) and B. subtilis (ATCC
6633); the Gram-negative bacteria E. coli (ATCC-25922) and
Pseudomonas aeruginosa (ATCC-27853); and for antifungal
activity against two pathogenic fungi viz. A. niger and C. albi-
cans. All the synthesized compounds were evaluated for anti-
microbial activity against four bacterial and two fungal
strains against norﬂoxacin and ﬂuconazole as standard. Anti-
microbial susceptibility testing was performed by the standard-
ized disc diffusion and the agar dilution methods of the
National Committee for Clinical Laboratory Standards. Inhib-
itory zone diameters were measured on Nutrient Agar (NA)
for bacteria and Potato Dextrose Agar (PDA) for fungi, with
conventional metrical ﬁlter paper discs (6 mm in diameter)
containing speciﬁed doses of compounds.
7.1. Antibacterial testing
The Mueller Hinton Agar medium, the Petri-plates, ﬁlter pa-
per discs and ﬂask plugged with cotton were sterilized by auto-
claving at 121 C (151 lb/sq. inch). In each sterilized Petri plate
(10 cm in diameter) about 30 mL of molten nutrient agar med-
ium inoculated with the respective strains of bacteria was
transferred aseptically. The plates were left at room tempera-
ture to allow solidiﬁcation. In each plate, four discs of 6 mm
diameter were placed on the medium which were previously
dipped into the solution of test compounds which were pre-
pared and labelled accordingly. The plates were kept undis-
turbed for at least 20 min in refrigerator to allow diffusion
of the solution properly in the nutrient agar medium. The
plates were incubated at 37 ± 1 C for 24 h.
7.2. Antifungal testing
The Potato Dextrose Agar medium, the Petri-plates, ﬁlter pa-
per discs and ﬂask plugged with cotton were sterilized by auto-
claving at 121 C (151 lb/sq. inch). In each sterilized Petri plate
(10 cm in diameter) about 30 mL of molten nutrient agar med-
ium inoculated with respective strains of fungi was transferred
aseptically. The plates were left at room temperature to allow
solidiﬁcation. In each plate, four discs of 6 mm diameter were
placed on the medium which were previously dipped into the
solution of test compounds which were prepared and labelled
accordingly. The plates were kept undisturbed for at least
20 min in refrigerator to allow diffusion of the solution prop-
erly in the nutrient agar medium. The plates were incubated at
25 ± 1 C for 24 h.
7.3. Minimum inhibitory concentration determination
The solution of the newly synthesized compounds and stan-
dard drugs was prepared at 500, 250, 125, 62.5, 31.25, 15.63,
7.8, 3.9, 1.95, 0.98, 0.48, 0.24, 0.12 lg/mL concentrations in
the wells of microplates by diluting in the liquid double
S396 V. Ugale et al.stranded nutrient broth. The bacterial suspensions used for
inoculation were prepared of 105 cfu/mL by diluting fresh cul-
tures at MacFarland 0.5 density (107 cfu/mL). Suspensions of
the bacteria at 105 cfu/mL concentration were inoculated to
the twofold diluted solution of the compounds. There were
104 cfu/mL bacteria in the wells after inoculations. Nutrient
broth was used for diluting the bacterial suspension and for
twofold dilution of the compound. DMSO, pure microorgan-
isms and pure media were used as control wells. Ten microli-
tres bacteria inocula were added to each well of the micro
dilution trays. The trays were incubated at 37 C in a humid
chamber and MIC endpoints were read after 24 h of incuba-
tion. For antifungal activity, same procedure was used. The
lowest concentration of the compound that completely inhibits
macroscopic growth was determined and minimum inhibitory
concentrations (MICs) were reported.Acknowledgements
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